503 related articles for article (PubMed ID: 19386443)
1. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
6. Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Shiau AC; Yu CY; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
J Radiat Res; 2010; 51(2):173-9. PubMed ID: 20339254
[TBL] [Abstract][Full Text] [Related]
7. Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly.
Hellebust TP; Kristensen GB; Olsen DR
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):713-8. PubMed ID: 19427739
[TBL] [Abstract][Full Text] [Related]
8. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
9. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
10. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
[TBL] [Abstract][Full Text] [Related]
13. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
Macdonald DM; Lin LL; Biehl K; Mutic S; Nantz R; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):618-24. PubMed ID: 18407429
[TBL] [Abstract][Full Text] [Related]
14. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
15. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
17. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
Huang EY; Wang CJ; Hsu HC; Hao Lin ; Chen HC; Sun LM
Gynecol Oncol; 2004 Oct; 95(1):101-8. PubMed ID: 15385117
[TBL] [Abstract][Full Text] [Related]
19. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
20. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
